"In 2002, Northside Hospital purchased the 41-bed Georgia Baptist Medical Center (in Cumming) and renamed it Northside Hospital-Forsyth. Since then, the facility has experienced continuous growth, expanding to 304 beds."

During the past decade, Northside Hospital-Forsyth conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 26 clinical trials were completed, i.e. on average, 70.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 24 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northside Hospital-Forsyth" #1 sponsor was "National Cancer Institute (NCI)" with 20 trials, followed by "SWOG Cancer Research Network" with 10 trials sponsored, "NRG Oncology" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northside Hospital-Forsyth" #1 collaborator was "National Cancer Institute (NCI)" with 30 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Northside Hospital-Forsyth" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Invasive Breast Carcinoma" (4 trials), "Recurrent Ovarian Carcinoma" (4 trials) and "Recurrent Breast Carcinoma" (3 trials). Many other conditions were trialed in "Northside Hospital-Forsyth" in a lesser frequency.

Most popular intervention types in "Northside Hospital-Forsyth" are "Other" (40 trials), "Drug" (34 trials), "Biological" (19 trials), "Radiation" (13 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (27 trials), "Quality-of-Life Assessment" (15 trials), "Computed Tomography" (7 trials), "Nivolumab" (7 trials) and "Carboplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Northside Hospital-Forsyth" are 33 trials for "All" genders, 15 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Northside Hospital-Forsyth". undefined are not yet recruiting, 9 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Northside Hospital-Forsyth, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Northside Hospital-Forsyth, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".